Gene editing outfit Editas has been one of the most successful tech IPOs of 2016 so far, with shares skyrocketing up 130 percent shortly after the company’s public debut. But the stock has now plummeted nearly 26 percent in after-hours trading over concerns it might not be able to legally use the technology it’s built upon.
Some on Twitter believe the drop to be part of a… Read More
Gene editing outfit Editas has been one of the most successful tech IPOs of 2016 so far, with shares skyrocketing up 130 percent shortly after the company’s public debut. But the stock has now plummeted nearly 26 percent in after-hours trading over concerns it might not be able to legally use the technology it’s built upon.
Some on Twitter believe the drop to be part of a… Read More